|
|
| Research article summary (published 11 Aug 2009): |
Flaviviral protease inhibitors identified by fragment-based library docking into a structure generated by molecular dynamics.
Full Abstract
Fragment-based docking was used to select a conformation for virtual screening from a molecular dynamics trajectory of the West Nile virus nonstructural 3 protease. This conformation was chosen from an ensemble of 100 molecular dynamics snapshots because it optimally accommodates benzene, the most common ring in known drugs, and two positively charged fragments (methylguanidinium and 2-phenylimidazoline). The latter fragments were used as probes because of the large number of hydrogen bond acceptors in the substrate binding site of the protease. Upon high-throughput docking of a diversity set of 18,694 molecules and pose filtering, only five compounds were chosen for experimental validation, and two of them are active in the low micromolar range in an enzymatic assay and a tryptophan fluorescence quenching assay. Evidence for specific binding to the protease active site is provided by nuclear magnetic resonance spectroscopy. The two inhibitors have different scaffolds (diphenylurea and diphenyl ester) and are promising lead candidates because they have a molecular weight of about 300 Da.
Author information
Author/s: Ekonomiuk, Dariusz (D); Su, Xun-Cheng (XC); Ozawa, Kiyoshi (K); Bodenreider, Christophe (C); Lim, Siew Pheng (SP); Otting, Gottfried (G); Huang, Danzhi (D); Caflisch, Amedeo (A);
Affiliation: Department of Biochemistry, University of Zurich, Winterthurerstrasse 190, CH-8057 Zurich, Switzerland.
Journal and publication information
Publication Type: Journal Article
Journal: Journal of medicinal chemistry (J Med Chem), published in United States. (Language: eng)
Reference: 2009-Aug; vol 52 (issue 15) : pp 4860-8
Dates: Created 2009/09/01; Completed 2009/09/21;
PMID: 19572550, status: MEDLINE (last retrieval date: 9/21/2009, IMS Date: )
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
Related articles
These are the highest related articles currently in the database:
- West Nile Virus NS2B/NS3 protease as an antiviral target.
30 Dec 2007 - Competitive inhibition of the dengue virus NS3 serine protease by synthetic peptides representing polyprotein cleavage sites.
18 May 2005 - Peptide inhibitors of Dengue virus NS3 protease. Part 1: Warhead.
19 Oct 2005 - Peptide inhibitors of dengue virus NS3 protease. Part 2: SAR study of tetrapeptide aldehyde inhibitors.
19 Oct 2005 - Potent cationic inhibitors of West Nile virus NS2B/NS3 protease with serum stability, cell permeability and antiviral activity.
24 Aug 2008 - Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus.
10 Mar 2006 - Cleavage targets and the D-arginine-based inhibitors of the West Nile virus NS3 processing proteinase.
13 Jan 2006 - HTS identifies novel and specific uncompetitive inhibitors of the two-component NS2B-NS3 proteinase of West Nile virus.
29 Nov 2007 - Binding of a noncovalent inhibitor exploiting the S' region stabilizes the hepatitis C virus NS3 protease conformation in the absence of cofactor.
22 Nov 2008 - Control of hepatitis C: a medicinal chemistry perspective.
11 Jan 2005
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.